Intramuscular administration of recombinant human c1-inhibitor could be an alternative for the treatment of acute attacks in patients with hereditary angioedema: A 3 year experience

Author(s):  
Anna Valerieva
2008 ◽  
Vol 121 (3) ◽  
pp. 797 ◽  
Author(s):  
J. Nuijens ◽  
R. Verdonk ◽  
B. Giannetti ◽  
S. Visscher ◽  
M. van Doorn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document